N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace

N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace
Dr. Shengmin Sang, a food scientist with N.C. A&T State University, licensed his patent for a family of novel aspirin-derived compounds to SARISA Therapeutics.
N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace
Source: University News

Comments are closed.